Antiherpes tetrapeptides having a substituted aspartic acid...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/300, 167/103

C07K 5/103 (2006.01) A61K 38/06 (2006.01) A61K 38/07 (2006.01) C07K 5/02 (2006.01) C07K 5/083 (2006.01) C07K 5/087 (2006.01) C07K 5/107 (2006.01) A61K 38/00 (2006.01)

Patent

CA 1340681

Disclosed herein are tetrapeptide derivatives of the formula X-NH-CHR1-C(W1)-NR2-CH[CH2C(O)-Y]-C(W2)-NH-CH- [CR3(R4)-COOH]-C(W3)-NH-CHR3-Z wherein X is a terminal group, for example, alkanoyl or phenylalkanoyl radicals, R1 and R5 are selected from amino acid or derived amino acid residues, R2 is hydrogen, alkyl or phenylalkyl, R3 and R4 are hydrogen or lower alkyl, W1, W2 and W3 are oxo or thioxo, Y is, for example, an alkoxy or a monosubstituted or disubstituted amino, and Z is a terminal group, for example, COOH or CH2OH. The derivatives are useful for treating herpes infections.

605061

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antiherpes tetrapeptides having a substituted aspartic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiherpes tetrapeptides having a substituted aspartic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiherpes tetrapeptides having a substituted aspartic acid... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1259674

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.